Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Ocular Therapeut (NQ: OCUL ) 8.530 -0.030 (-0.35%) Streaming Delayed Price Updated: 11:05 AM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Ocular Therapeut < Previous 1 2 3 4 5 6 7 Next > Nike, Lululemon, Dick's Sporting Goods And Other Big Losers From Friday October 03, 2022 U.S. stocks closed lower with the Dow Jones dropping 500 points on Friday. Here is the list of some big stocks recording losses in the previous session. Via Benzinga Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday October 03, 2022 Gainers FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37. Via Benzinga Recap: Ocular Therapeutix Q2 Earnings August 08, 2022 Ocular Therapeutix (NASDAQ:OCUL) reported its Q2 earnings results on Monday, August 8, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Via Benzinga Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session September 30, 2022 Gainers Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session September 27, 2022 Gainers Via Benzinga Avidity Biosciences, Kronos Worldwide And Some Other Big Stocks Moving Lower On Tuesday September 27, 2022 U.S. stocks traded lower, with the Dow Jones dropping around 180 points on Tuesday. Here are some big stocks recording losses in today’s session. Via Benzinga Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday September 30, 2022 Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares climbed 50.7% to close at $2.11 on Thursday after B of A Securities initiated coverage on the stock with a Buy rating and $7 price target. Via Benzinga Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday September 28, 2022 Gainers Via Benzinga Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session September 27, 2022 Gainers Via Benzinga Ocular Therapeutix's Wet AMD Candidate Shows Sustained, Comparable Clinical Activity Vs. Eylea September 27, 2022 Via Benzinga Ocular Therapeutix™ Announces Interim 7-month Data from U.S. Phase 1 Clinical Trial of OTX-TKI for the Treatment of Wet AMD September 27, 2022 From Ocular Therapeutix, Inc. Via Business Wire Ocular Therapeutix™ To Present Data at the American Academy of Ophthalmology (AAO) 2022 Annual Meeting September 22, 2022 From Ocular Therapeutix, Inc. Via Business Wire Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket September 22, 2022 Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem... Via Benzinga Ocular Therapeutix™ to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 07, 2022 From Ocular Therapeutix, Inc. Via Business Wire Ocular Therapeutix™ to Present at the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference August 10, 2022 From Ocular Therapeutix, Inc. Via Business Wire Ocular Therapeutix™ Reports Second Quarter 2022 Financial Results and Business Update August 08, 2022 From Ocular Therapeutix, Inc. Via Business Wire Ocular Therapeutix™ To Report Second Quarter 2022 Financial Results July 25, 2022 From Ocular Therapeutix, Inc. Via Business Wire Earnings Scheduled For August 8, 2022 August 08, 2022 Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings for its second quarter. Via Benzinga Ocular Therapeutix™ Announces Organizational Changes to Support Development for Retinal Diseases June 08, 2022 From Ocular Therapeutix, Inc. Via Business Wire Ocular Therapeutix™ to Present at the Jefferies Healthcare Conference June 01, 2022 From Ocular Therapeutix, Inc. Via Business Wire Stocks That Hit 52-Week Lows On Friday May 27, 2022 During Friday's session, 59 stocks hit new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Thursday May 26, 2022 On Thursday, 94 companies set new 52-week lows. Via Benzinga Expert Ratings for Ocular Therapeutix May 10, 2022 Over the past 3 months, 4 analysts have published their opinion on Ocular Therapeutix (NASDAQ:OCUL) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding... Via Benzinga Ocular Therapeutix™ Reports First Quarter 2022 Financial Results and Business Update May 09, 2022 From Ocular Therapeutix, Inc. Via Business Wire Earnings Scheduled For May 9, 2022 May 09, 2022 Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million. Via Benzinga Ocular Therapeutix™ To Present Pre-Clinical Data at the American Society of Gene & Cell Therapy (ASGCT) 25th Annual Meeting May 03, 2022 From Ocular Therapeutix, Inc. Via Business Wire The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs May 03, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Via Benzinga The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More May 02, 2022 Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pharma earnings, clinical readouts and pipeline updates moved stocks... Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session April 29, 2022 Gainers Ocular Therapeutix (NASDAQ:OCUL) shares moved upwards by 12.3% to $4.01 during Friday's after-market session. The company's market cap stands at $307.7 million. Via Benzinga Ocular Therapeutix™ to Report First Quarter 2022 Financial Results April 26, 2022 From Ocular Therapeutix, Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.